NeuralStem competitors

NeuralStem's competitors include InVivo Therapeutics, ImCheck Therapeutics, MedDay and Bicycle Therapeutics
Add company...
NeuralStem
NeuralStem, a biotherapeutics company, aims to apply stem cell research and technology to treat diseases of the central nervous system.
InVivo Therapeutics
InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries.
ImCheck Therapeutics
ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .
MedDay
MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases.
Bicycle Therapeutics
Bicycle Therapeutics is a company developing a technology for the creation of new generation biotherapeutics.
Founding Date
Founding Date
1996
Founding Date
2005
Founding Date
2015
Founding Date
2011
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Rockville, US HQ
Locations
Cambridge, US HQ
Locations
Marseille, FR HQ
Locations
Paris, FR HQ
Locations
Babraham, GB HQ
Cambridge, US
Employees
Employees
11
Employees
37
Employees
15
Employees
741% decrease
Employees
594% increase
Valuation ($)
Valuation ($)
16.7 m
Valuation ($)
15.1 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Facebook likes
Facebook likes
1.2 k
Facebook likes
12.4 k
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Twitter followers
Twitter followers
2.2 k
Twitter followers
1.2 k
Twitter followers
N/A
Twitter followers
192
Twitter followers
577

Financial

Revenue (est.)
Revenue (est.)
$16.2k (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
£1.3m (FY, 2017)
Net income
Net income
($21.1m) (FY, 2016)
Net income
($26.7m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
(£10.1m) (FY, 2017)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 1.1m (12 months ago)
Latest funding round
$ 38.5m (over 2 years ago)
Latest funding round
$ 51.4m (over 1 year ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 75.2m
Total funding raised
$ 22.9m
Total funding raised
$ 48.9m
Total funding raised
$ 89.4m
For sources of this data, please see the company profileDownload Excel

View company profiles

InVivo Therapeutics
wdxefcqufszuzezftuxetqsqxt
HQ
Cambridge, US
Employees
37

InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries.

View company
ImCheck Therapeutics
HQ
Marseille, FR
Employees
15

ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .

View company
MedDay
HQ
Paris, FR
Employees
74↓ 1% decrease

MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases.

View company
Bicycle Therapeutics
HQ
Babraham, GB
Employees
59↑ 4% increase

Bicycle Therapeutics is a company developing a technology for the creation of new generation biotherapeutics.

View company